Vaccines Summit Market Analysis and Reports | UK Conference Series

Market Analysis - Vaccines Summit 2018

29th International Conference on Vaccines and Immunization

Theme: Highlights of latest technologies and innovations in Vaccines and Immunization

Immunization/Vaccination is a major pasture in eradication of diseases. Conventional approaches to vaccine draft were to enfeeble the human pathogen, Vaccinology is the science of vaccine evolution and how the immune system responds to vaccines, and additionally it includes perpetual workup of Immunization programs, vaccine safety and its efficacy.

Vaccination is important and effective way of preventing infectious disease. That is why majority of countries in the world adopted in second half of the twentieth century to implement various immunization programs. Effectiveness of vaccination is unambiguously proven by regression up-to clearance of many diseases preventable by vaccination. Influence of vaccination can be best illustrated on eradication of smallpox in the world. Thanks to vaccination this deadly disease was overcome, in seventies of the last century this disease was the cause of many deaths. In countries with low immunization rate, i.e. with not adequate collective immunity, many vaccination preventable diseases occur.

 Vaccines Summit 2018 piles up all the Researchers and Healthcare professionals under one roof of to talk on the current research/public health programs and their scientific progress.

Importance & Scope:

Conference series invites all professionals around the world to attend “29th International Conference on Vaccines and Immunization” features with theme "Highlights of latest technologies and innovations in Vaccines and Immunization" on March 19-20, 2018 in London, UK. This conference brings a novel and International compound of massive and form cognizance on vaccines and vaccination, leading universities stir up the conference, an ideal dais to quantify out proficiency, enrich collaborations across trade and world, and assess upgrading technologies across the world.

For more Details: vaccines-immunization.conferenceseries.com

Why London?

London is the capital and most populous city of England and the United Kingdom. London is a leading global city, in the arts, commerce, education, entertainment, fashion, finance, healthcare, media, professional services, research and development, tourism, and transport. It is one of the world’s leading financial centres and has the fifth- or sixth-largest metropolitan area GDP in the world.

This City is the world cultural capital. It is the world’s most-visited city as measured by international arrivals and has the world’s largest city airport system measured by passenger traffic. London’s universities form the largest concentration of higher education institutes in Europe, and a 2014 report placed it first in the world university rankings. According to the report London also ranks first in the world in software, multimedia development and design, and shares first position in technology readiness.

This city has the greatest concentration of top class universities in the world and its international student population of around 110,000 is larger than any other city in the world. London is home to five major medical schools – Barts and The London School of Medicine and Dentistry, King’s College London School of Medicine (the largest medical school in Europe), Imperial College School of Medicine, UCL Medical School and St George’s, University of London – and has a large number of affiliated teaching hospitals. It is also a major centre for biomedical research, and three of the UK’s eight academic health science centres are based in the city – Imperial College Healthcare, King’s Health Partners and UCL Partners (the largest such centre in Europe).

The presence of universities, hospitals, labs and other professional services, together with key installations of the U.K. make it favourite destination for scientific meetings.

 

Major Hospitals

London

United Kingdom

Worldwide

Barts Health NHS Trust

Addenbrooke's Hospital

Stanford Hospitals and Clinics

Barts Health NHS Trust

King's Mill Hospital

Oxford Medical School

Evelina Children's Hospital - St Thomas' Hospital

Nottingham University Hospitals

Mayo Clinic Scottsdale AZ

Royal London Hospital

St Thomas' Hospital

University of Maryland Medical Center

St Mary's Hospital

Papworth Hospital

University of Texas Cancer Centre

St. George's Hospital, London

Royal Devon and Exeter Hospital

Harvard Medical School

The Institute of Cancer Research

King's College Hospital

Cleveland Clinic

 

 

Major Vaccines Associations and Societies

London

Europe

Worldwide

Vaccine Research Association

 

European Federation of Immunological societies (EFIS)

The International Union of Immunological Societies

Italian Society of Allergy, Asthma and Clinical Immunology

The Society for Mucosal Immunology

British Society for Immunology

German Society for Allergology and Clinical Immunology

British Society for Immunology

British Society of Allergy and Clinical Immunology

Federation of African Immunological Societies

Child Health and Society

French Society of Allergology and Clinical Immunology

Federation of Clinical Immunology Societies

Dutch Society of Allergology

Infectious Diseases Society of America

British Global and Travel Health Association

Romanian Society of Allergology and Clinical Immunology

Immune Deficiency Foundation

Czech Society of Allergology and Clinical Immunology

European Federation of Immunological Societies

 

 

Industries Associated with Vaccines

London

United Kingdom

Worldwide

Cambridge Healthcare Supplies Ltd

GlaxoSmithKline

MSD (Merck)

DiscoveRx

AstraZeneca (Med Immune)

Pfizer

Novartis

Pfizer UK

Vaxon Biotech

Parexel

Oxford BioMedica

Sanofi

Praxisb Unico

Vectura Group

Sinovac Biotech

The Binding Site

Proximagen

Vaxxas Nanopatch

The Jenner Institute

Hikma Pharmaceuticals

Antitope (Abzena)

Treos Bio

AAH Pharmaceuticals

GlaxoSmithKline

 

 

Universities Associated with Vaccine Research

London

United Kingdom

Worldwide

Aston University

Heriot-Watt University

Stanford University

Kingston University 

Kingston University 

The University of Sydney

London City University

Surrey Clinical Research Centre

University of Cambridge

Newman University

University College London

Johns Hopkins University

University of London

Oxford University

Harvard University

University of Oxford

University of East Anglia

University of California

University of Alabama

St George's University of London

University of Oxford

 

 

 

 

 

 

 

 

 

 

 

 

Market Value and Market Growth on Vaccines Research in the Past and Upcoming 10 Years:

The global vaccine market is one of the fastest growing segments and new predictions estimate the value of the market to reach between $48 billion and more than $70 billion over the next five to eight years.

According to a new report released by Transparency Market Research, the value of the global human vaccines market is expected to grow from a $28.3 billion in 2015 to $72.5 billion in 2024. The projection would represent a compound annual growth rate (CAGR) of 11.2% from 2016 to 2024. Even though the dollar figure is large and growing, vaccines still only account 3% of the market share within the global pharmaceutical industry. The report broke down expectations by segments. By age group, paediatric vaccines accounted for 57.5% of the share in 2015, but adult vaccines are expected to grow at a 13.2% CAGR during the forecast period. When the research group analysed the market by product, they found the pneumococcal segment to have the majority share in 2015, but expect hepatitis products to demonstrate strong growth through 2024. By vaccine type, the conjugate vaccines held the majority share in 2015, but the combination vaccines were expected to have the largest CAGR.

Estimated Impact of Immunization on Vaccines Preventable Diseases (WHO Report):

Funding for Vaccines Research:

United Kingdom:

In 2007, the Medical Research Council reviewed its vaccine research portfolio and concluded that it needed to strengthen its translational research by accelerating basic vaccine research into product development and clinical practice and using vaccine research to inform immunisation policies. Five projects have received funding, including a study to monitor the effectiveness of HPV vaccines in teenage girls. There are some academic centres which focus on vaccine research. Some, such as the Jenner Institute in Oxford, specialise in researching novel candidate vaccines. The limiting step for such institutes is the expense of producing batches of novel vaccines and testing them in clinical trials. In 2005, in an effort to encourage UK based pharmaceutical manufacture (including vaccines) the government invested £30m in establishing a National Bio-manufacturing Centre. This facility can produce a wide variety of biopharmaceuticals (including vaccines) under contract from the private sector and academia.

Global Funds:

·         United Nations Children’s Fund (UNICEF)

·         Centre for Disease Control and Prevention (CDC)

·         Bill and Melinda Gates Foundation

·         American Academy of Paediatrics (AAP)

·         Vaccine Foundation (V Foundation)

·         Rockefeller Foundation (RF)

·         National Institute of Health (NIH)

·         Children’s Vaccine Initiative (CVI)

·         Global Alliance for Vaccines and Immunization (GAVI)

Top 10 pharmaceutical companies based on global vaccine revenues in 2015 and 2022 (in million U.S. dollars):

Target Audience:

The conference discusses the latest research outcomes and technological advancements in the field and brings together leading Paediatrics, Immunologists, Physicians, Research Scholars, Students along with Industrial and Vaccines Research professionals to exchange share their views on critical aspects of Vaccines research. The event is designed in a way to provide an exclusive platform for new researchers, scholars and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Vaccination. Vaccines summit 2018 will comprise leading keynote speakers, session speakers, poster presenters who will be presenting their research on the topics Human Vaccines Against Infectious Diseases, Cancer, Malaria and TB Vaccines, Immunizations and Bioterrorism, Combination and Conjugate Vaccines, DNA and Synthetic Vaccines, Live, Attenuated, Inactivated and Subunit Vaccines, Travel and Edible vaccines, Paediatric Vaccination, Vaccines for Immune mediated Diseases, Veterinary Vaccines, Vaccines against drugs‎, Vaccines and Autism, Vaccine Safety and Efficacy, Geriatric Immunization, Vaccines for Pregnant women and Neonates, Immunology and Animal Models, Animal and Plant Derived Vaccines, Vectors, Adjuvants and Delivery Systems, Vaccines for unconventional diseases, Cellular Immunology and Latest Innovations, Clinical Immunology & Cancer Immunotherapy, Molecular and Structural Immunology, Antibodies: Engineering and Therapeutics, Regulatory, Societal and Legislation Aspects of Vaccines etc.

Projections:

The global market for vaccines has reported an impressive development in its market valuation, thanks to the increasing rate of birth globally. The rising incidence of diseases such as polio, influenza, hepatitis has also fuelled demand from the global paediatric vaccines market to a great extent.

The vaccines segment dominates the global vaccine products market. The market for live attenuated vaccines has registered the highest growth among all the segments, based on technology. By diseases, the infectious diseases segment has occupied the leading position at present. However, the rising prevalence of cancer, specifically Leukaemia, in kids is projected to register the fastest growth in this market in the coming years. This will further boost the global market for vaccines in the near future. 

North America leads the global market for vaccines and is closely followed by Europe. However, the market for vaccines in Asia Pacific is likely to report the fastest growth during the period from 2012 to 2018 owing to the high birth rate in China and India.

Though the growth prospects for the global market for vaccines looks lucrative, low accessibility to vaccines in developing economies, together with strict regulations for the usage of these vaccines, is likely to hamper the growth of this market over the next few years.